← Back to home
Pharma · Diagnostics & Market Access · 2025
Global market study for a new diagnostics offering.
An AI-augmented market and ecosystem assessment for a global pharma client developing a diagnostics solution for earlier identification of patients with a high-burden chronic disease.
Client: Global pharmaceutical client
45+
Global stakeholders engaged
45%
Less time and cost
Live
In active market rollout
The challenge
The client needed to understand clinical need, stakeholder acceptance, market potential, and ecosystem requirements across regions before committing to a global rollout of a new diagnostics offering.
Our approach
- 01Agentic used Continuum to structure and evaluate global interview input from payers, patients, physicians, and academic experts.
- 02The platform translated qualitative findings into product and go-to-market implications across the key regions.
- 03Together with the client, we defined the clinical, commercial, and ecosystem conditions required to bring the offering to market.
Outcome
- — Product concept advanced into active market rollout.
- — 45% reduction in project time and cost versus a traditional market study.
- — Aligned view across clinical, commercial, and access stakeholders on what it takes to win.
More work
Pharma · Analytics Strategy
Assessing analytics maturity across a global pharma organization.
Private Equity · Investment Operations
Document intelligence platform for a leading private equity investor.
Financial Services · Market Monitoring